Ensysce Biosciences Inc
NASDAQ:ENSC
Ensysce Biosciences Inc
NASDAQ:ENSC
Price:
0.395
USD
-0.38%
Market Closed
Market Cap:
$1.4m
Balance Sheet
Balance Sheet Decomposition
Ensysce Biosciences Inc
Ensysce Biosciences Inc
Balance Sheet Decomposition is not available for
Ensysce Biosciences Inc
Ensysce Biosciences Inc
Balance Sheet
Ensysce Biosciences Inc
Ensysce Biosciences Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
2
|
2
|
1
|
0
|
12
|
3
|
1
|
0
|
|
| Cash |
2
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
12
|
3
|
1
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
3
|
2
|
1
|
2
|
|
| Total Current Assets |
2
|
2
|
1
|
0
|
16
|
5
|
2
|
5
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
13
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
200
|
203
|
195
|
0
|
1
|
1
|
0
|
0
|
|
| Total Assets |
202
N/A
|
205
+1%
|
197
-4%
|
13
-93%
|
16
+27%
|
6
-64%
|
3
-54%
|
6
+107%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
3
|
0
|
0
|
3
|
2
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
3
|
2
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
13
|
4
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
3
|
0
|
17
|
10
|
3
|
2
|
|
| Long-Term Debt |
0
|
0
|
1
|
1
|
4
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
7
|
7
|
7
|
13
|
4
|
0
|
0
|
0
|
|
| Total Liabilities |
7
N/A
|
7
+3%
|
10
+39%
|
14
+37%
|
24
+72%
|
10
-60%
|
3
-68%
|
2
-38%
|
|
| Equity | |||||||||
| Common Stock |
190
|
192
|
181
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
2
|
3
|
1
|
86
|
111
|
122
|
130
|
|
| Additional Paid In Capital |
5
|
3
|
3
|
0
|
78
|
107
|
121
|
133
|
|
| Total Equity |
195
N/A
|
197
+1%
|
186
-6%
|
1
N/A
|
8
-558%
|
4
+53%
|
0
+91%
|
4
N/A
|
|
| Total Liabilities & Equity |
202
N/A
|
205
+1%
|
197
-4%
|
13
-93%
|
16
+27%
|
6
-64%
|
3
-54%
|
6
+107%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
25
|
25
|
24
|
0
|
0
|
0
|
0
|
1
|
|
Switch to:
Switch to:
See Also
Discover More
